AMORPHOUS LETERMOVIR AND SOLID PHARMACEUTICAL FORMULATIONS THEREOF FOR ORAL ADMINISTRATION

The immediate release formulations of amorphous Letermovir are intended for use in methods of prophylaxis or methods of treatment of diseases associated with the group of Herpesviridae, preferably associated with cytomegalovirus (CMV), even more preferably associated with human cytomegalovirus (HCMV...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: RINDERMANN, NICOLE, SCHICKANEDER, CHRISTIAN, BOTHE, CLEMENS, MÄRTENS, WELLJANNE, LIMMERT, MICHAEL, BERWE, MATHIAS, SCHWAB, WILFRIED, JUNG, DIRK
Format: Patent
Sprache:eng ; pol
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator RINDERMANN, NICOLE
SCHICKANEDER, CHRISTIAN
BOTHE, CLEMENS
MÄRTENS, WELLJANNE
LIMMERT, MICHAEL
BERWE, MATHIAS
SCHWAB, WILFRIED
JUNG, DIRK
description The immediate release formulations of amorphous Letermovir are intended for use in methods of prophylaxis or methods of treatment of diseases associated with the group of Herpesviridae, preferably associated with cytomegalovirus (CMV), even more preferably associated with human cytomegalovirus (HCMV).
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_PL3010891TT3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>PL3010891TT3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_PL3010891TT33</originalsourceid><addsrcrecordid>eNqNiksKwjAQQLtxIeodxgMILd3ockgTEkgyZTJx0U0pEleihXp__OABXD14762rAQNxbykn8Fo0Bzo7BowdJPKug94iB1Q6i1PowRCH7FEcxQRiNWsyHwnE74pdcNEl4e-wrVbX6baU3Y-bam-0KHso82Msyzxdyr08x963dVMfT41I2_7zvACxVDLa</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>AMORPHOUS LETERMOVIR AND SOLID PHARMACEUTICAL FORMULATIONS THEREOF FOR ORAL ADMINISTRATION</title><source>esp@cenet</source><creator>RINDERMANN, NICOLE ; SCHICKANEDER, CHRISTIAN ; BOTHE, CLEMENS ; MÄRTENS, WELLJANNE ; LIMMERT, MICHAEL ; BERWE, MATHIAS ; SCHWAB, WILFRIED ; JUNG, DIRK</creator><creatorcontrib>RINDERMANN, NICOLE ; SCHICKANEDER, CHRISTIAN ; BOTHE, CLEMENS ; MÄRTENS, WELLJANNE ; LIMMERT, MICHAEL ; BERWE, MATHIAS ; SCHWAB, WILFRIED ; JUNG, DIRK</creatorcontrib><description>The immediate release formulations of amorphous Letermovir are intended for use in methods of prophylaxis or methods of treatment of diseases associated with the group of Herpesviridae, preferably associated with cytomegalovirus (CMV), even more preferably associated with human cytomegalovirus (HCMV).</description><language>eng ; pol</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20191129&amp;DB=EPODOC&amp;CC=PL&amp;NR=3010891T3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20191129&amp;DB=EPODOC&amp;CC=PL&amp;NR=3010891T3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>RINDERMANN, NICOLE</creatorcontrib><creatorcontrib>SCHICKANEDER, CHRISTIAN</creatorcontrib><creatorcontrib>BOTHE, CLEMENS</creatorcontrib><creatorcontrib>MÄRTENS, WELLJANNE</creatorcontrib><creatorcontrib>LIMMERT, MICHAEL</creatorcontrib><creatorcontrib>BERWE, MATHIAS</creatorcontrib><creatorcontrib>SCHWAB, WILFRIED</creatorcontrib><creatorcontrib>JUNG, DIRK</creatorcontrib><title>AMORPHOUS LETERMOVIR AND SOLID PHARMACEUTICAL FORMULATIONS THEREOF FOR ORAL ADMINISTRATION</title><description>The immediate release formulations of amorphous Letermovir are intended for use in methods of prophylaxis or methods of treatment of diseases associated with the group of Herpesviridae, preferably associated with cytomegalovirus (CMV), even more preferably associated with human cytomegalovirus (HCMV).</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNiksKwjAQQLtxIeodxgMILd3ockgTEkgyZTJx0U0pEleihXp__OABXD14762rAQNxbykn8Fo0Bzo7BowdJPKug94iB1Q6i1PowRCH7FEcxQRiNWsyHwnE74pdcNEl4e-wrVbX6baU3Y-bam-0KHso82Msyzxdyr08x963dVMfT41I2_7zvACxVDLa</recordid><startdate>20191129</startdate><enddate>20191129</enddate><creator>RINDERMANN, NICOLE</creator><creator>SCHICKANEDER, CHRISTIAN</creator><creator>BOTHE, CLEMENS</creator><creator>MÄRTENS, WELLJANNE</creator><creator>LIMMERT, MICHAEL</creator><creator>BERWE, MATHIAS</creator><creator>SCHWAB, WILFRIED</creator><creator>JUNG, DIRK</creator><scope>EVB</scope></search><sort><creationdate>20191129</creationdate><title>AMORPHOUS LETERMOVIR AND SOLID PHARMACEUTICAL FORMULATIONS THEREOF FOR ORAL ADMINISTRATION</title><author>RINDERMANN, NICOLE ; SCHICKANEDER, CHRISTIAN ; BOTHE, CLEMENS ; MÄRTENS, WELLJANNE ; LIMMERT, MICHAEL ; BERWE, MATHIAS ; SCHWAB, WILFRIED ; JUNG, DIRK</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_PL3010891TT33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; pol</language><creationdate>2019</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>RINDERMANN, NICOLE</creatorcontrib><creatorcontrib>SCHICKANEDER, CHRISTIAN</creatorcontrib><creatorcontrib>BOTHE, CLEMENS</creatorcontrib><creatorcontrib>MÄRTENS, WELLJANNE</creatorcontrib><creatorcontrib>LIMMERT, MICHAEL</creatorcontrib><creatorcontrib>BERWE, MATHIAS</creatorcontrib><creatorcontrib>SCHWAB, WILFRIED</creatorcontrib><creatorcontrib>JUNG, DIRK</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>RINDERMANN, NICOLE</au><au>SCHICKANEDER, CHRISTIAN</au><au>BOTHE, CLEMENS</au><au>MÄRTENS, WELLJANNE</au><au>LIMMERT, MICHAEL</au><au>BERWE, MATHIAS</au><au>SCHWAB, WILFRIED</au><au>JUNG, DIRK</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>AMORPHOUS LETERMOVIR AND SOLID PHARMACEUTICAL FORMULATIONS THEREOF FOR ORAL ADMINISTRATION</title><date>2019-11-29</date><risdate>2019</risdate><abstract>The immediate release formulations of amorphous Letermovir are intended for use in methods of prophylaxis or methods of treatment of diseases associated with the group of Herpesviridae, preferably associated with cytomegalovirus (CMV), even more preferably associated with human cytomegalovirus (HCMV).</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; pol
recordid cdi_epo_espacenet_PL3010891TT3
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title AMORPHOUS LETERMOVIR AND SOLID PHARMACEUTICAL FORMULATIONS THEREOF FOR ORAL ADMINISTRATION
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T12%3A01%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=RINDERMANN,%20NICOLE&rft.date=2019-11-29&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EPL3010891TT3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true